OpenURL Connection Search

Select item for more details and to access through your institution.

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.
Published in:
1993
By:
- Winston, Drew J.;
- Ho, Winston G.;
- Bartoni, Kathy;
- Du Mond, Charles;
- Ebeling, Darlene F.;
- Buhles, William C.;
- Champlin, Richard E.;
- Winston, D J;
- Ho, W G;
- Bartoni, K;
- Du Mond, C;
- Ebeling, D F;
- Buhles, W C;
- Champlin, R E
Publication type:
journal article
Ganciclovir Treatment of Cytomegalovirus Colitis in AIDS: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study.
Published in:
Journal of Infectious Diseases, 1993, v. 167, n. 2, p. 278, doi. 10.1093/infdis/167.2.278
By:
- Dieterich, Douglas T.;
- Kotler, Donald P.;
- Busch, David F.;
- Crumpacker, Clyde;
- Du Mond, Charles;
- Dearmand, Bernadette;
- Buhles, William
Publication type:
Article
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers.
Published in:
2017
By:
- Lesko, Lawrence J.;
- Offman, Elliot;
- Brew, Christine Taylor;
- Garza, Dahlia;
- Benton, Wade;
- Mayo, Martha R.;
- Romero, Alain;
- Du Mond, Charles;
- Weir, Matthew R.
Publication type:
journal article
Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.
Published in:
Nephrology Dialysis Transplantation, 2018, v. 33, n. 7, p. 1207, doi. 10.1093/ndt/gfx241
By:
- Brunelli, Steven M;
- Spiegel, David M;
- Mond, Charles Du;
- Oestreicher, Nina;
- Winkelmayer, Wolfgang C;
- Kovesdy, Csaba P
Publication type:
Article

Found: 4

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.

Ganciclovir Treatment of Cytomegalovirus Colitis in AIDS: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study.

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers.

Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.